| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 0 | 2.119 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | 0 | 815 | 2.358 | 3.801 | 1 | 4 | 11.935 | 1 |
| Total Expenses - EUR | - | - | 2.881 | 537.771 | 1.364.307 | 445.862 | 122.864 | 106.426 | 21.900 | 27.314 |
| Gross Profit/Loss - EUR | - | - | -2.881 | -536.956 | -1.361.949 | -442.061 | -122.863 | -106.422 | -9.965 | -27.312 |
| Net Profit/Loss - EUR | - | - | -2.881 | -536.956 | -1.361.949 | -442.072 | -122.863 | -106.422 | -9.965 | -27.312 |
| Employees | - | - | 0 | 0 | 28 | 15 | 0 | 1 | 0 | 1 |
Check the financial reports for the company - Activeimmunity S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 373.377 | 342.004 | 237.585 | 140.953 | 65.573 | 60.734 | 58.299 |
| Current Assets | - | - | 248 | 126.003 | 36.271 | 48.575 | 37.459 | 37.910 | 35.165 | 18.816 |
| Inventories | - | - | 0 | 5.986 | 11.013 | 11.621 | 12.171 | 13.373 | 12.158 | 556 |
| Receivables | - | - | 202 | 19.561 | 24.135 | 22.408 | 23.173 | 23.245 | 21.501 | 17.173 |
| Cash | - | - | 45 | 100.457 | 1.124 | 14.546 | 2.114 | 1.292 | 1.506 | 1.087 |
| Shareholders Funds | - | - | -2.662 | -539.139 | -1.890.648 | 81.405 | -43.264 | -149.820 | -159.331 | -185.753 |
| Social Capital | - | - | 219 | 645 | 632 | 2.378.903 | 2.326.148 | 2.333.365 | 2.326.289 | 2.313.288 |
| Debts | - | - | 2.909 | 1.040.123 | 2.269.237 | 204.756 | 221.675 | 253.358 | 255.311 | 262.901 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7499 - 7499" | |||||||||
| CAEN Financial Year |
7490
|
|||||||||
Comments - Activeimmunity S.r.l.